Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Genomic epidemiology of Salmonella Typhi in Central Division, Fiji, 2012 to 2016.

Autor: Davies MR; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia., Duchene S; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia., Valcanis M; Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Jenkins AP; Centre for Ecosystem Management, Edith Cowan University, Western Australia.; School of Public Health, University of Sydney, Sydney, NSW, Australia., Jenney A; New Vaccines Group, Murdoch Children's Research Institute, Victoria, Australia.; College of Medicine, Nursing and Health Sciences, Fiji National University, Suva, Fiji., Rosa V; Fiji Centre for Disease Control, Fiji Ministry of Health, Suva, Fiji., Hayes AJ; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia., Strobel AG; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia., McIntyre L; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia., Lacey JA; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute of Infection and Immunity, Victoria, Australia., Klemm EJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom., Wong VK; Department of Medicine, University of Cambridge, Cambridge, United Kingdom., Sahukhan A; Fiji Centre for Disease Control, Fiji Ministry of Health, Suva, Fiji., Thomson H; New Vaccines Group, Murdoch Children's Research Institute, Victoria, Australia., Page A; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.; Quadram Institute Bioscience, Norwich Research Park, Norfolk, United Kingdom., Hocking D; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia., Wang N; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia., Tudravu L; Colonial War Memorial Hospital, Suva, Fiji., Rafai E; Fiji Ministry of Health and Medical Services, Suva, Fiji., Dougan G; Department of Medicine, University of Cambridge, Cambridge, United Kingdom., Howden BP; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.; Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Crump JA; Centre for International Health, Otago Medical School, University of Otago, Dunedin, New Zealand., Mulholland K; New Vaccines Group, Murdoch Children's Research Institute, Victoria, Australia.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Strugnell RA; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.

Publikováno v: The Lancet regional health. Western Pacific [Lancet Reg Health West Pac] 2022 Jun 16; Vol. 24, pp. 100488. Date of Electronic Publication: 2022 Jun 16 (Print Publication: 2022).

Innovative vaccine approaches-a Keystone Symposia report.

Autor: Cable J; PhD Science Writer, New York, New York., Rappuoli R; GSK, Siena, Italy., Klemm EJ; Wellcome Trust, Bloomsbury, London, UK., Kang G; Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India., Mutreja A; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID) and Department of Medicine, University of Cambridge, Cambridge, UK., Wright GJ; Cell Surface Signalling Laboratory, Wellcome Sanger Institute, Hinxton, UK.; Department of Biology, Hull York Medical School, and York Biomedical Research Institute, University of York, York, UK., Pizza M; GSK, Siena, Italy., Castro SA; Division of Molecular Microbiology, School of Life Sciences, University of Dundee, Dundee, UK., Hoffmann JP; Departments of Pediatrics and Medicine, Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, Louisiana., Alter G; Ragon Institute of MGH, MIT and Harvard, Harvard Medical School, Cambridge, Massachusetts.; Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Carfi A; Moderna Inc., Cambridge, Massachusetts., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK., Krammer F; The Tisch Cancer Institute and Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York., Gupta RK; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID) and Department of Medicine, University of Cambridge, Cambridge, UK.; Africa Health Research Institute, Durban, South Africa., Wagner CE; Department of Bioengineering, McGill University, Montreal, Quebec, Canada., Machado V; Measles and Respiratory Viruses Laboratory, WHO/NIC, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil., Modjarrad K; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland., Corey L; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington.; Department of Medicine, University of Washington School of Medicine, Seattle, Washington.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., B Gilbert P; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Dougan G; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID) and Department of Medicine, University of Cambridge, Cambridge, UK., Lurie N; Coalition for Epidemic Preparedness Innovations, Oslo, Norway.; Harvard Medical School, Boston, Massachusetts., Bjorkman PJ; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California., Chiu C; Department of Infectious Disease, Imperial College London, London, UK., Nemes E; Division of Immunology, Department of Pathology, South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Gordon SB; Malawi Liverpool Wellcome Research Programme, Blantyre, Malawi., Steer AC; Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.; Department of General Medicine, The Royal Children's Hospital, Melbourne, Victoria, Australia., Rudel T; Microbiology Biocenter, University of Würzburg, Würzburg, Germany., Blish CA; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford Immunology Program, Stanford University School of Medicine, Stanford, California.; Chan Zuckerberg Biohub, San Francisco, California., Sandberg JT; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm, Sweden., Brennan K; National Children's Research Centre, Crumlin and School of Medicine, Trinity College Dublin, Dublin, Ireland., Klugman KP; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia., Stuart LM; Immunology Program, Benaroya Research Institute at Virginia Mason, Seattle, Washington.; Bill & Melinda Gates Foundation, Seattle, Washington., Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Karp CL; Bill & Melinda Gates Foundation, Seattle, Washington.

Publikováno v: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2022 May; Vol. 1511 (1), pp. 59-86. Date of Electronic Publication: 2022 Jan 14.

Population structure and antimicrobial resistance patterns of Salmonella Typhi isolates in urban Dhaka, Bangladesh from 2004 to 2016.

Autor: Rahman SIA; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh., Dyson ZA; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom., Klemm EJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom., Khanam F; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh., Holt KE; Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Department of Infection Biology, Faculty of Infections and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom., Chowdhury EK; Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh., Dougan G; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom., Qadri F; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.

Publikováno v: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2020 Feb 27; Vol. 14 (2), pp. e0008036. Date of Electronic Publication: 2020 Feb 27 (Print Publication: 2020).

An African Salmonella Typhimurium ST313 sublineage with extensive drug-resistance and signatures of host adaptation.

Autor: Van Puyvelde S; Department of Biomedical Sciences, Institute of Tropical Medicine, Nationalestraat 155, 2000, Antwerp, Belgium. svanpuyvelde@itg.be.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK. svanpuyvelde@itg.be.; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium. svanpuyvelde@itg.be., Pickard D; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.; Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0SP, UK., Vandelannoote K; Department of Biomedical Sciences, Institute of Tropical Medicine, Nationalestraat 155, 2000, Antwerp, Belgium., Heinz E; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.; Department of Vector Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK., Barbé B; Department of Clinical Sciences, Institute of Tropical Medicine, Nationalestraat 155, 2000, Antwerp, Belgium., de Block T; Department of Biomedical Sciences, Institute of Tropical Medicine, Nationalestraat 155, 2000, Antwerp, Belgium., Clare S; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK., Coomber EL; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK., Harcourt K; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK., Sridhar S; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.; Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0SP, UK., Lees EA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.; Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0SP, UK., Wheeler NE; Centre for Genomic Pathogen Surveillance, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK., Klemm EJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK., Kuijpers L; Department of Clinical Sciences, Institute of Tropical Medicine, Nationalestraat 155, 2000, Antwerp, Belgium.; Department of Microbiology and Immunology, KU Leuven, Herestraat 49-box 1030, 3000, Leuven, Belgium., Mbuyi Kalonji L; Department of Microbiology, National Institute for Biomedical Research, Av. De La Démocratie no, 5345, Kinshasa, Democratic Republic of the Congo.; Department of Microbiology, University Hospital of Kinshasa, Kinshasa, Democratic Republic of the Congo., Phoba MF; Department of Microbiology, National Institute for Biomedical Research, Av. De La Démocratie no, 5345, Kinshasa, Democratic Republic of the Congo.; Department of Microbiology, University Hospital of Kinshasa, Kinshasa, Democratic Republic of the Congo., Falay D; Department of Pediatrics, University Hospital of Kisangani, Avenue Munyororo C/Makiso, Kisangani, BP 2012, Democratic Republic of the Congo., Ngbonda D; Department of Pediatrics, University Hospital of Kisangani, Avenue Munyororo C/Makiso, Kisangani, BP 2012, Democratic Republic of the Congo., Lunguya O; Department of Microbiology, National Institute for Biomedical Research, Av. De La Démocratie no, 5345, Kinshasa, Democratic Republic of the Congo.; Department of Microbiology, University Hospital of Kinshasa, Kinshasa, Democratic Republic of the Congo., Jacobs J; Department of Clinical Sciences, Institute of Tropical Medicine, Nationalestraat 155, 2000, Antwerp, Belgium.; Department of Microbiology and Immunology, KU Leuven, Herestraat 49-box 1030, 3000, Leuven, Belgium., Dougan G; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.; Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0SP, UK., Deborggraeve S; Department of Biomedical Sciences, Institute of Tropical Medicine, Nationalestraat 155, 2000, Antwerp, Belgium.

Publikováno v: Nature communications [Nat Commun] 2019 Sep 19; Vol. 10 (1), pp. 4280. Date of Electronic Publication: 2019 Sep 19.